New American Thyroid Association Guidelines Include Recommendation for Veracyte's Afirma(R) Gene Expression Classifier to Rule Out Cancer in Indeterminate Thyroid Nodules
October 15, 2015Afirma GEC is the only molecular test with high enough sensitivity and negative predictive value to be an option for use in lieu of diagnostic surgery to rule out cancer in patients whose thyroid nodules are deemed indeterminate following cytopathology.
More »
Astute Medical Announces Signing Of Distribution Agreement With FOSUNPHARMA For NephroCheck® Test In China With $20 Million Financing
October 12, 2015The deal expands global access to first-of-its-kind FDA-cleared test for acute kidney injury risk.
More »
Celtaxsys Begins US Enrollment for Phase 2 Trial of Acebilustat Anti-Inflammatory Therapy for Cystic Fibrosis
October 8, 2015Celtaxsys, a clinical stage drug development company focused on advancing care for patients suffering from orphan inflammatory diseases, commenced the US arm of a phase 2 trial for acebilustat. EU sites anticipated to begin enrollment early 2016.
More »